We can’t show the full text here under this license. Use the link below to read it at the source.
Immiscible Phase Separation‐Driven Microfabrication of Gelatin Methacryloyl Scaffolds for BMP‐2 Delivery and Osteogenic Enhancement
Making Gelatin Scaffolds Using Phase Separation to Deliver BMP-2 and Improve Bone Growth
AI simplified
Abstract
Injectable micro-scaffolds (mS-GelMA) demonstrate high biocompatibility and functionality with human mesenchymal stem cells (hMSCs).
- Controlled porosity and stability of mS-GelMA are achieved through (SFL).
- SFL allows for precise shape and degradation control, improving micro-particle uniformity compared to conventional methods.
- Incorporating (TMPTA) enhances the scaffolds' drug delivery and regenerative potential.
- Cellular assays indicate that hMSCs within mS-GelMA scaffolds show excellent viability, migration, and osteogenic differentiation.
- SFL-fabricated GelMA scaffolds offer a potential solution for combining injectability with structural complexity in tissue engineering.
AI simplified
Key numbers
95%
Increase
Achieved with 100 µL in scaffolds.
15 min
Degradation Time
Fastest degradation time for 100 µL concentration.
Higher than control
Osteogenic Activity Increase
Measured via alkaline phosphatase activity in BMP-2-loaded scaffolds.